Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: August 17, 2017
What is the patent landscape for Glycopyrrolate, and what generic Glycopyrrolate alternatives are available?
Glycopyrrolate is a drug marketed by Watson Labs, Appco Pharma Llc, Natco Pharma Ltd, Vintage Pharms, Rising Pharms Inc, Nexgen Pharma, Luitpold, Hikma Intl Pharms, Somerset Theraps Llc, Sun Pharm Inds Ltd, Dr Reddys Labs Ltd, Par Pharm, Hikma Farmaceutica, Epic Pharma Llc, Teva Parenteral, Amneal Pharms Co, Abraxis Pharm, Aurolife Pharma Llc, Santos Biotech, Hospira, and Leading Pharma Llc. and is included in twenty-six NDAs.| Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 26 |
| Suppliers / Packagers: see list | 27 |
| Bulk Api Vendors: see list | 50 |
| Clinical Trials: see list | 93 |
| Patent Applications: see list | 2,082 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | GLYCOPYRROLATE at DailyMed |
| Drug Class | Anticholinergic |
| Mechanism of Action | Cholinergic Antagonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 086178-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Teva Parenteral | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 081169-001 | Sep 10, 1991 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Santos Biotech | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 091182-001 | Feb 3, 2014 | AA | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Amneal Pharms Co | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 208973-001 | Jun 15, 2017 | AP | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Watson Labs | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 086900-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,320 others who get our Drug Patent Expiration Alerts:
